Recent Updates
Meet Us at DCAT Week 2026, New York, Lotte New York Palace | Mar 23-26 | Room 1402
New Nitrosamine Compounds Now Available
Now Operating in San Diego, USA
Impurity Product Detail

Leflunomide Related Compound B

Explore technical data, documentation access, molecular information and enquiry options for this Clearsynth research product.

Product Code: CS-T-04169 Impurity Research Use Only
Leflunomide Related Compound B
Category
Impurity
API Family
Leflunomide
Product Code
CS-T-04169
Research Status
For Laboratory Use

Leflunomide Related Compound B

Leflunomide Impurity
Stock Status: In Stock
Live

CAT No.
CS-T-04169
CAS No.
108605-62-5
Molecular Formula
C₁₂H₉F₃N₂O₂
Molecular Weight
270.21
Login to view price
There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal or Veterinary use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
CAS No.
108605-62-5
Product Code
CS-T-04169
M.F.
C₁₂H₉F₃N₂O₂
M.W.
270.21
Smiles
O=C(/C(C#N)=C(O)\C)NC1=CC=C(C(F)(F)F)C=C1
Category
Impurity
API Family
Leflunomide
Storage Condition
Store at refrigerator (2-8°C) for long term storage
IUPAC Name
(E)-2-Cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)but-2-enamide
References
"Kirsch, B,M,, et al,: Arthritis Research and Therapy, 7, 3, R694, (2005)"
Synonyms
Teriflunomide-E Isomer
Application Notes
"rac A77 1726 is the active metabolite of Leflunomide, a potent disease-modifying antirheumatic drug used in the treatment of rheumatoid arthritis. LEF-M interferes with dendritic cell function. The second Phase III study evaluating the efficacy of Genzyme’s teriflunomide therapy against relapsing forms of multiple sclerosis found the once-daily oral drug to be no less effective than injectable interferon beta 1a (Rebif®). "
Purity by HPLC
98.26%
Hazard Compound
Refer MSDS for accurate information.
Overview
"rac A77 1726 is the active metabolite of Leflunomide, a potent disease-modifying antirheumatic drug used in the treatment of rheumatoid arthritis. LEF-M interferes with dendritic cell function. The second Phase III study evaluating the efficacy of Genzyme’s teriflunomide therapy against relapsing forms of multiple sclerosis found the once-daily oral drug to be no less effective than injectable interferon beta 1a (Rebif®). "

Refund Policy

We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of material handover. We have invested in the highest quality packaging materials and use international logistics partners to service our customers. If there is an issue with one or more of our products, it must be reported to us within 45 days of your receiving shipment for refund or account credit eligibility.

Downloading MSDS…
Quick Enquiry Email Us
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.